Synergy Pharmaceuticals (SGYP): Why It Should Be In Your Portfolio

Synergy Pharmaceuticals (NASDAQ: SGYP) Synergy Pharmaceuticals has been the topic of quite a bit of debate lately. The stock has also been the victim of quite a bit of short manipulation. However, regardless of the debate and regardless of the manipulation, I believe that SGYP is a strong stock for just about any portfolio. The … Read more

Synergy Pharmaceuticals (SGYP) Stock Claims More Gains

Synergy Pharmaceuticals (NASDAQ: SGYP) Synergy Pharmaceuticals is having a decent day in the market today as the stock works on a recovery from Friday’s and Monday’s market-wide declines. In my opinion, a strong recovery is long over due. Today, we’ll talk about what we’re seeing in the market, why SGYP is a strong opportunity for … Read more

Synergy Pharmaceuticals (SGYP) Stock Runs With The Bulls: Will It Last?

Synergy Pharmaceuticals Inc (NASDAQ: SGYP) Synergy Pharmaceuticals has been having a rough time in the market lately and the crash in the stock market didn’t make things much better. However, today Synergy Pharmaceuticals seems to be one of the stocks that is recovering from declines most quickly.  And, in my opinion, it’s for a good reason. … Read more

Synergy Pharmaceuticals (SGYP) Stock: A Catalyst Is Coming!

Synergy Pharmaceuticals Inc (NASDAQ: SGYP) Synergy Pharmaceuticals has been a very interesting stock to watch lately. After releasing data from it’s Phase 3-A study into the effectiveness of plecanatide, SGYP soared In the market. However, since then, we’ve seen declines overall. Today, we’ll talk about what we’ve seen from SGYP and signs that the stock … Read more

Synergy Pharmaceuticals (SGYP) Stock | Yet Another Reason To Invest

Synergy Pharmaceuticals Inc (NASDAQ: SGYP) Synergy Pharmaceuticals stock has been one of my favorite topics recently. The company’s advancements with regard to their experimental drug, known as plecanatide, have been incredible. Now, the company is giving investors even more reason to put on the bullish face. They have brought on a new executive to help … Read more